Advertisement

Innovative Drug May Revolutionize the Treatment of Early-Stage Breast Cancer

Researchers from a large-scale international study are now investigating whether standard endocrine therapy can be improved by the additional of palbociclib, a kinase inhibitor.

 MedicalXpress

click me